🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

RecruitingNAAges 20 Years - 60 YearsAllAlexandria University
NCT07150858 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Residual bone height not less than 5 mm measured from crestal bone to sinus floor. * Both genders. * Good oral hygiene * No previous surgery or radiation treatment on the maxillary sinus Exclusion Criteria: * Recent radiation therapy in maxilla. * Uncontrolled systemic diseases such as diabetes mellitus. * Heavy smoker (those who smoke ≥ 25 cigarettes a day). * Alcohol abuse. * Patient on anticoagulant drug * Severe allergic rhinitis. * Tumor or large cyst in the maxillary sinus. * Oroantral fistula. * Presence of acute or chronic sinus pathoses or sinus membrane perforation.(
💊

What it tests

  • Erythropoietin and albumin PRF gel + implant placement
  • Albumin PRF gel +implant placement
📍

Where

1 site
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University
Alexandria, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy